日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

RNF186 中的蛋白质截短变体 R179X 可预防溃疡性结肠炎

Rivas Manuel A, Graham Daniel, Sulem Patrick, Stevens Christine, Desch A Nicole, Goyette Philippe, Gudbjartsson Daniel, Jonsdottir Ingileif, Thorsteinsdottir Unnur, Degenhardt Frauke, Mucha Sören, Kurki Mitja I, Li Dalin, D'Amato Mauro, Annese Vito, Vermeire Severine, Weersma Rinse K, Halfvarson Jonas, Paavola-Sakki Paulina, Lappalainen Maarit, Lek Monkol, Cummings Beryl, Tukiainen Taru, Haritunians Talin, Halme Leena, Koskinen Lotta L E, Ananthakrishnan Ashwin N, Luo Yang, Heap Graham A, Visschedijk Marijn C, MacArthur Daniel G, Neale Benjamin M, Ahmad Tariq, Anderson Carl A, Brant Steven R, Duerr Richard H, Silverberg Mark S, Cho Judy H, Palotie Aarno, Saavalainen Päivi, Kontula Kimmo, Färkkilä Martti, McGovern Dermot P B, Franke Andre, Stefansson Kari, Rioux John D, Xavier Ramnik J, Daly Mark J, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar J P, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen J V, Milgrom R, Proctor D, Regueiro M, Schumm P L, Sharma Y, Stempak J M, Targan S R, Wang M H

Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor

Cathelicidin 通过抑制 CD36 受体来抑制脂质积累和肝脂肪变性。

Hoang-Yen Tran, D; Hoang-Ngoc Tran, D; Mattai, S A; Sallam, T; Ortiz, C; Lee, E C; Robbins, L; Ho, S; Lee, J E; Fisseha, E; Shieh, C; Sideri, A; Shih, D Q; Fleshner, P; McGovern, D P B; Vu, M; Hing, T C; Bakirtzi, K; Cheng, M; Su, B; Law, I; Karagiannides, I; Targan, S R; Gallo, R L; Li, Z; Koon, H W

Crohn's ileitis after liver transplantation from a living related donor with Crohn's disease

接受克罗恩病患者亲属活体肝移植后发生克罗恩性回肠炎

Papadakis, K A; Matuk, R; Abreu, M T; Vasiliauskas, E A; Fleshner, P R; Lechago, J; Tran, T; Poordad, F F; Martin, P; Vierling, J; Targan, S R

Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease

克罗恩病患者受累和未受累亲属中抗酿酒酵母甘露聚糖抗体的家族性表达

Sutton, C L; Yang, H; Li, Z; Rotter, J I; Targan, S R; Braun, J

HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations

HLA II类单倍型与犹太人(阿什肯纳兹犹太人)和非犹太白种人群炎症性肠病的关联

Trachtenberg, E A; Yang, H; Hayes, E; Vinson, M; Lin, C; Targan, S R; Tyan, D; Erlich, H; Rotter, J I

Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses

通过多种非参数分析检测到克罗恩病与主要组织相容性复合体区域的关联。

Yang, H; Plevy, S E; Taylor, K; Tyan, D; Fischel-Ghodsian, N; McElree, C; Targan, S R; Rotter, J I

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

抗酿酒酵母甘露聚糖抗体与抗中性粒细胞胞浆自身抗体在炎症性肠病中的联合应用:患病率和诊断作用

Quinton, J F; Sendid, B; Reumaux, D; Duthilleul, P; Cortot, A; Grandbastien, B; Charrier, G; Targan, S R; Colombel, J F; Poulain, D

Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews

炎症性肠病家族史风险:犹太人和非犹太人之间的差异

Yang, H; McElree, C; Roth, M P; Shanahan, F; Targan, S R; Rotter, J I

Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers

溃疡性结肠炎:一种遗传异质性疾病,由遗传(HLA II 类)和亚临床(抗中性粒细胞胞浆抗体)标志物定义。

Yang, H; Rotter, J I; Toyoda, H; Landers, C; Tyran, D; McElree, C K; Targan, S R